This company has been acquired
Augmedix Past Earnings Performance
Past criteria checks 0/6
Augmedix's earnings have been declining at an average annual rate of -7.1%, while the Healthcare Services industry saw earnings growing at 14.8% annually. Revenues have been growing at an average rate of 33.8% per year.
Key information
-7.1%
Earnings growth rate
92.7%
EPS growth rate
| Healthcare Services Industry Growth | 1.7% |
| Revenue growth rate | 33.8% |
| Return on equity | -227.7% |
| Net Margin | -46.2% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Augmedix, Inc. (NASDAQ:AUGX) Stock's 38% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jun 19
Is Augmedix, Inc. (NASDAQ:AUGX) Trading At A 40% Discount?
May 21Augmedix, Inc. (NASDAQ:AUGX) Shares Slammed 29% But Getting In Cheap Might Be Difficult Regardless
Apr 25Augmedix: Secular AI Tailwinds, But Still Unattractive Risk-Reward
Mar 24Augmedix, Inc. (NASDAQ:AUGX) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
Nov 09Augmedix reports Q2 results
Aug 08Augmedix: A Splendid Long-Term Investing Opportunity
Jan 21Revenue & Expenses Breakdown
How Augmedix makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 52 | -24 | 35 | 14 |
| 31 Mar 24 | 49 | -20 | 31 | 12 |
| 31 Dec 23 | 45 | -19 | 29 | 11 |
| 30 Sep 23 | 41 | -20 | 28 | 11 |
| 30 Jun 23 | 37 | -21 | 27 | 11 |
| 31 Mar 23 | 34 | -24 | 27 | 11 |
| 31 Dec 22 | 31 | -24 | 26 | 10 |
| 30 Sep 22 | 29 | -24 | 25 | 9 |
| 30 Jun 22 | 27 | -21 | 24 | 9 |
| 31 Mar 22 | 24 | -19 | 22 | 8 |
| 31 Dec 21 | 22 | -17 | 21 | 7 |
| 30 Sep 21 | 20 | -16 | 20 | 6 |
| 30 Jun 21 | 19 | -17 | 19 | 5 |
| 31 Mar 21 | 17 | -16 | 17 | 4 |
| 31 Dec 20 | 16 | -16 | 16 | 5 |
| 30 Sep 20 | 16 | -15 | 15 | 5 |
| 30 Jun 20 | 15 | -18 | 14 | 6 |
| 31 Mar 20 | 15 | -19 | 15 | 7 |
| 31 Dec 19 | 14 | -18 | 14 | 7 |
| 31 Dec 18 | 11 | -24 | 17 | 7 |
Quality Earnings: AUGX is currently unprofitable.
Growing Profit Margin: AUGX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AUGX is unprofitable, and losses have increased over the past 5 years at a rate of 7.1% per year.
Accelerating Growth: Unable to compare AUGX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AUGX is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (13.9%).
Return on Equity
High ROE: AUGX has a negative Return on Equity (-227.69%), as it is currently unprofitable.